Transcatheter aortic valve replacement (TAVR) has gained over time a major reduction in
procedural complications. Despite this, clinically relevant bleeding still occurs in a non …

Atrial fibrillation (AF) is the most common arrhythmia in patients with valvular heart disease,
and it can be associated with adverse patient outcomes. However, the need of …

ABSTRACT The Society of Thoracic Surgeons 2023 clinical practice guidelines for the
surgical management of atrial fibrillation incorporate the most recent evidence for surgical …

Background Patients with atrial fibrillation (AF) undergoing transcatheter aortic valve
implantation (TAVI) have been associated with worse short-term outcomes compared with …

Percutaneous structural interventions have a major impact on the morbidity, mortality, and
quality of life of patients by providing a lower-risk alternative to cardiac surgery. However …

Background New onset atrial fibrillation (NOAF) is a common occurrence after transcatheter
aortic valve replacement (TAVR) and portends a poorer prognosis. The optimal strategy for …

Previous reports on the impact of preexisting atrial fibrillation (AF) on clinical outcomes after
transcatheter aortic valve implantation (TAVI) have presented limited data on the relative …

Background Atrial fibrillation (AF) is the most common arrhythmia and an important risk
factor for adverse cardiac outcomes, including heart failure and stroke. Moreover, AF has …

Recent highlights from the International Journal of Cardiology Heart & Vasculature:
Transcatheter aortic valve implantation - PMC Skip to main content Here's how you know …

Transcatheter aortic valve implantation has transformed the therapeutic landscape for
symptomatic aortic stenosis by providing a less invasive option for high-risk or inoperable …